Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (Unaudited)

v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 1,360,000 $ 2,950,000
General and administrative 981,000 1,208,000
Total operating expenses 2,341,000 4,158,000
Loss from operations (2,341,000) (4,158,000)
Other income (expense):    
Interest income (expense), net 37,000 220,000
Foreign exchange gain (loss), net 3,000 (18,000)
Total other income (expense), net 40,000 202,000
Net loss $ (2,301,000) $ (3,956,000)
Net loss per common share, basic $ (0.23) $ (0.39)
Net loss per common share, diluted $ (0.23) $ (0.39)
Weighted average number of common shares, basic 10,174 10,174
Weighted average number of common shares, diluted 10,174 10,174